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SUMMARY – We present a case of a 50-year-old man with advanced liver cirrhosis and na-
tive valve infective endocarditis caused by methicillin-resistant Staphylococcus epidermidis. Bacterial 
infections are one of the most common complications of liver cirrhosis, but reports of infective en-
docarditis in patients with liver cirrhosis are relatively rare. Because of vulnerability of patients with 
advanced cirrhosis for developing infections, it is necessary to pay attention to the pathogens that are 
sometimes considered contamination and actively seek for the seat of infection, even in less expected 
areas (e.g., native heart valves without a history of heart disease).
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Introduction
Bacterial infections are one of the most common 
complications of liver cirrhosis, especially when it 
comes to decompensated liver cirrhosis1. The most 
common infections are spontaneous bacterial peri-
tonitis, urinary tract infections, pneumonia, and 
cellulitis1,2. Reports of infective endocarditis in pa-
tients with liver cirrhosis are relatively rare3. The 
prevalence of infections is 25%-30% and they are 
responsible for 30%-50% of fatal outcomes in these 
patients1. Reduced clearance of bacteria, as well as 
changes in intestinal mucosa may potentiate bacterial 
translocation. Impaired infection defense in cirrhosis 
may also contribute to a decreased level of comple-
ment components, impaired function of macrophag-
es, and decreased level of expression of HLA-DR on 
monocytes1,4. Blood stasis, the existence of shunts 
through peripheral collateral veins and portal hyper-
tension may contribute to persistence of bacteremia, 
as well as a variety of endoscopic procedures, thus in-
creasing the tendency to develop endocarditis5,6.
In the absence of systemic inflammatory response 
syndrome (SIRS), a Model for End-Stage Liver Dis-
ease (MELD) score of >18 is associated with 12% in-
hospital mortality, whereas in the presence of SIRS 
the mortality increases to 43%7,8. The frequency of iso-
lation of multiresistant bacteria in patients with cir-
rhosis reaches 40% in some tertiary hospitals7,9,10. 
The incidence of infective endocarditis is approxi-
mately 2-6 cases per 100 000 people per year, and has 
not decreased over the last 30 years11. In the U.S., 
about 10 000 to 15 000 new cases of infective endo-
carditis are annually diagnosed on average, and ac-
cording to a French study, the incidence is 33.8 cases 
per million12. Despite advances in medicine, mortality 
rates are still between 10% and 30%11,13. It is more 
common in people older than 60 years, men, injection 
drug users, related to poor dental hygiene and dental 
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infections, patients with structural heart disease and 
those with artificial valves. It is also more common 
in patients with previous acute infective endocardi-
tis, presence of an intravascular device, patients on 
chronic hemodialysis, and patients with HIV infec-
tion12. It has also been recognized that diabetes as a 
comorbidity in patients with infective endocarditis is 
an independent predictor of mortality11,14.
Case Report
A 50-year-old patient with decompensated liver 
cirrhosis of ethylic genesis was admitted for pre-
transplantation screening. Cirrhosis was diagnosed 
six years before and the patient was hospitalized on 
three occasions in a regional hospital with enceph-
alopathy as the leading symptom. Seven months 
before current hospitalization, right hallux redness 
appeared followed by elevated temperature up to 39 
˚C, with no trauma or injury of the skin. He was 
diagnosed with osteomyelitis and the hallux was am-
putated under local anesthesia. Three hours later, he 
suffered a minor cerebrovascular accident with left 
sided hemiparesis. After three days, he underwent 
computed tomography (CT) of the brain, which 
showed “a small lesion on the right”. Approximately 
2.5 months after the stroke, he underwent stationary 
physical rehabilitation. During the last weeks of re-
habilitation, he felt low back pain accompanied with 
fever and two months before current hospitalization 
he was diagnosed with spondylodiscitis at L5S1. 
Vancomycin therapy was administered for three 
weeks. Several days before current hospitalization, 
he was hospitalized in a regional hospital due to en-
cephalopathy and febrility up to 39 ˚C. Afterwards, 
he was transferred to our hospital.
At admission, the patient presented with fever 
(38.3 ˚C), blood pressure 130/85 mm Hg, heart rate 
76/min; he was disoriented, dysarthric, with icteric 
skin, mucous membranes, and sclerae. His abdomen 
was distended with ascites, painless, with palpable 
spleen 1 cm. There was mild lower leg edema with 
trophic skin changes and slightly weakened strength 
of the left hand. Auscultatory examination of the lungs 
was normal and systolic diastolic murmur was heard 
over the precordium. Initial laboratory tests were as 
follows: E 3.24x1012/L, Hb106 g/L, Hct 0.301 L/L, 
MCV 92.9 fl, platelet 31x109/L, L 5.98x109/L, PT 
0.46, INR 1.6, total bilirubin 180 μmol/L, AST 44 
U/L, ALT 26 U/L, GGT 49 U/L, ALP 123 U/L, 
ammonia 62 μmol/L, creatinine 119 μmol/L, CRP 
62.1 mg/L. MELD score was 18 and the classifica-
tion of cirrhosis severity was Child Pugh C.
Given the above, the suspected diagnosis was 
infective endocarditis, which was confirmed by tr-
ansthoracic and transesophageal ultrasound, which 
revealed mildly sclerotic mitral valve with floating 
vegetation at the top of the atrial side of the anterior 
Fig. 2. Transesophageal ultrasound: all three aortic valve 
leaflets show thickening of endocarditic nature.
Fig. 1. Transesophageal ultrasound: mitral valve with 
floating vegetation at the top of the atrial side of the an-
terior mitral leaflet, with a thread-like formation on the 
edge of the same leaflet in the space of the left ventricle.
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mitral leaflet, 1x0.4 cm, with thread-like formation 
on the edge of the same leaflet in the space of the left 
ventricle (Fig. 1) and with the presence of trivial mi-
tral insufficiency. Also, in all three aortic valve leaflets, 
thickening of endocarditic nature (Fig. 2) was found 
with accompanying aortic regurgitation grade 2-3+. 
The left ventricle properly contracted with ejection 
fraction of about 65% and no regional disturbances in 
motility. Once coagulase-negative staphylococci and 
twice Staphylococcus epidermidis resistant to oxacillin 
were isolated from blood cultures. Urine culture was 
sterile and there were no signs of spontaneous bacte-
rial peritonitis. Vancomycin was included in patient 
therapy.
On day 12 of admission to our institution, the pa-
tient developed left bundle branch block (LBBB) and 
then total atrioventricular (AV) block. A temporary 
pacemaker was embedded and inotropic and vasoac-
tive support was introduced. The further course was 
complicated by intense abdominal pain. Ultrasound 
found splenic infarction followed by multiorgan fail-
ure with fatal outcome on day 16 of his stay in our hos-
pital. In the post mortem reported tracheal aspirate, 
isolation of Klebsiella pneumoniae ESBL 104 CFU/mL 
and Acinetobacter baumanii (carbapenem-sensitive) ≥105 
CFU/mL was reported. Autopsy was performed and 
revealed liver cirrhosis, ascites, endocarditis of mi-
tral and aortal valve, pulmonary edema, right basal 
bronchopneumonia, intra-alveolar hemorrhage, and 
infarctions of the spleen.
Discussion
The best studied infectious diseases in cirrhotic 
patients are spontaneous bacterial peritonitis, pneu-
monia and urinary tract infection. Reports of infec-
tive endocarditis in patients with liver cirrhosis are 
relatively rare. Thus, in the study by Hung et al.3, 
bacterial endocarditis during three years of monitor-
ing was recorded in 0.3% of patients with cirrhosis, 
but compared with patients who did not have cir-
rhosis, patients with cirrhosis had a higher risk of 
developing bacterial endocarditis. In a study of 166 
patients with infective endocarditis, 29% of them 
had chronic liver disease, and it was the most com-
mon comorbidity in the study group11. Chronic liver 
disease as a comorbidity in patients with infective 
endocarditis was found to be an independent predic-
tor of mortality. Cirrhotic patients had a higher mor-
tality (51% vs. 17.7%) and it was associated with the 
severity of liver disease15.
Coagulase-negative staphylococci (CoNS) are 
the predominant bacteria that colonize the skin and 
therefore they are the most common bacteria that 
contaminate blood cultures. Blood cultures positive 
for these bacteria are typically considered by physi-
cians to be clinically insignificant. The role of CoNS, 
including Staphylococcus epidermidis, as true pathogens 
is usually appreciated only in patients with prosthetic 
material16.  
Native valve endocarditis (NVE) has been con-
sidered primarily a community-acquired infection, 
although healthcare-associated cases are becoming 
increasingly common. CoNS were uncommon causes 
of NVE, but emerging association between NVE due 
CoNS and healthcare acquisition was validated in a 
large prospective multicenter investigation17,18. CoNS 
were responsible for 8% of NVE cases not associated 
with injection drug use, whereas 49% of cases were 
acquired in a healthcare setting. The same study found 
that the overall rate of methicillin (oxacillin)-resistant 
isolates among CoNS that caused NVE was 41%, 22% 
of which were community-acquired17,18.
According to a retrospective study involving 757 
patients with infective endocarditis, the average time 
from symptom onset to the initiation of antibiotic 
therapy was 52 days and the longest period was 489 
days19. The incidence of embolism in patients with 
left-sided infective endocarditis in a study of 629 pa-
tients was 21% and 9.8% of patients had more than 
one episode. Among patients with embolism, 7.4% of 
them had  central nervous system, 27.8% lower limb, 
and 5.3% spleen embolism19.
The incidence of spondylodiscitis in patients with 
infective endocarditis according to different reports 
ranges from 5% to 15%20,21. In the study by Le Moal et 
al.21, spondylodiscitis in all cases described was diag-
nosed prior to the diagnosis of infective endocarditis, 
was more common in men, and affected lumbar spine 
in 71% of cases.
According to another two studies22,23 in patients 
with infective endocarditis, the incidence of cases of 
simultaneous involvement of mitral and aortic valve 
was approximately 12%. Although individual suc-
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cessful cases have been described24, valve replace-
ment is performed less frequently in cirrhotic patients 
and operative mortality is extremely high in stage B 
and C patients. Due to the presence of severe hepatic 
dysfunction, cardiac surgery is often not undertaken 
even when indicated15. There was a case of simulta-
neous mitral valve replacement for acute endocarditis 
and orthotopic liver transplantation for end-stage liver 
disease25. 
We presented a rare case of a patient with ad-
vanced liver cirrhosis and native valve infective en-
docarditis caused by methicillin (oxacillin)-resistant 
Staphylococcus epidermidis (MRSE) with probably the 
first symptoms of embolism seven months before the 
diagnosis of endocarditis (osteomyelitis of the right 
leg, ischemic cerebrovascular accident, then spondy-
lodiscitis at L5S1) and later spleen microembolism, 
total AV block, followed by the development of mul-
tiple organ failure and death. There were no history 
data indicating the possible entry points of infection 
(there was no information on endoscopic procedures 
or the presence of a central venous catheter), but con-
sidering that the patient had advanced liver cirrhosis 
and therefore impaired immunity, it was possible that 
only slight interruption of the skin continuity could 
lead to the introduction of resistant pathogens, prob-
ably in terms of hospital environment. There was no 
information on previous heart disease or valve dis-
ease or on the existence of cardiac murmur either. 
Vancomycin therapy for spondylodiscitis had been 
initiated two months before current hospitaliza-
tion and lasted for 3 weeks, which probably helped 
a little, but also masked the clinical picture. At the 
time of the diagnosis of infective endocarditis, the 
patient had a high MELD score and active infection 
with a resistant microorganism, so the patient was 
not considered eligible for surgical treatment or liver 
transplantation.
Endocarditis in patients with advanced liver cir-
rhosis (Child Pugh score C) may be a therapeutic 
challenge. Vulnerability of patients with advanced 
cirrhosis for developing infections with no clearly vis-
ible entrance, and the pathogens that are sometimes 
considered contamination should lead to more active 
search for the seat of infection, even in less expected 
areas (e.g., native heart valves without a history of 
heart disease).
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Sažetak
ENDOKARDITIS NATIVNE VALVULE UZROKOVAN METICILIN-REZISTENTNIM SOJEM 
BAKTERIJE STAPHYLOCOCCUS EPIDERMIDIS U BOLESNIKA S UZNAPREDOVALOM CIROZOM 
JETRE 
G. Cavrić, D. Ilić, K. Njerš, I. Prkačin i D. Bartolek Hamp   
Prikazujemo slučaj 50-godišnjeg muškarca s uznapredovalom cirozom jetre i endokarditisom nativne valvule uzroko-
vane meticilin rezistentnim sojem bakterije Staphylocoocus epidermidis. Bakterijske infekcije jedne su od najčešćih kompli-
kacija ciroze jetre, ali su slučajevi infektivnog endokarditisa u bolesnika s cirozom jetre relativno rijetki. Zbog osjetljivosti 
bolesnika s uznapredovalom cirozom za razvoj infekcija potrebno je obratiti pozornost i na patogene koje ponekad sma-
tramo kontaminacijom te aktivno tražiti mjesto infekcije, čak i u manje očekivanim područjima (kao što su nativne srčane 
valvule bez povijesti ranije srčane bolesti). 
Ključne riječi: Endokarditis, bakterijski; Srčani zalisci, bolesti; Jetrena ciroza, alkoholna; Meticilin, rezistencija;  Staphyloco-
ccus epidermidis; Prikazi slučaja
